Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Investors

Analyst coverage

FIRMANALYST
Lehman BrothersPeter Welford; Philippa Gardner
Morgan StanleyKarl D Bradshaw, PhD
Bank Sal. Oppenheim Martin Vögtli
Bank Vontobel AGOdile Rundquist, PhD
Kepler EquitiesFlorian Gaiser, PhD CFA
Helvea SA Olav Zilian, M.D. Ph.D
Bank am BellevueBob Pooler
Piper JaffraySam Fazeli; Michael Aitkenhead